We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+28.77%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$190M
AUM Growth
+$44.6M
Cap. Flow
+$16.9M
Cap. Flow %
8.92%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$16.3M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
+$587K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$124M 65.29%
22,070,213
+3,000,000
+16% +$16.3M
ALKS icon
2
Alkermes
ALKS
$8.82B
$60.5M 31.89%
1,030,639
– –
VVUS
3
DELISTED
Vivus Inc
VVUS
$4.86M 2.57%
296,562
– –
RCKT icon
4
Rocket Pharmaceuticals
RCKT
$348M
$480K 0.25%
+12,778
New +$587K

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q3 2015 Portfolio in Review

As of Q3 2015, Meditor Group held 4 positions worth $190M, up 31% from $145M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group deployed $16.9M of net new capital in Q3 2015, opening 1 new position and adding to 1 existing holding. Its largest new stake was Rocket Pharmaceuticals: 12,778 shares worth $480K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Meditor Group's largest Q3 2015 buy was Rocket Pharmaceuticals: 12,778 shares worth $480K.
  • Meditor Group added most to Exelixis in Q3 2015, an estimated $16.3M increase.
  • Meditor Group's ten largest holdings make up 100% of its $190M portfolio in Q3 2015.
  • Meditor Group opened 1 new position and closed 0 in Q3 2015.
  • Meditor Group's portfolio value rose 31% quarter-over-quarter to $190M.

Based on Meditor Group's 13F filing for Q3 2015, filed 8 Oct 2015.